Sanara MedTech Inc. (SMTI) stock
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73−0.03 (-0.09%)
Close on Nov 17, 2026Market cap $300.72MP/E –Yield –
Sanara MedTech gross margin
Gross margin is gross profit as a percentage of revenue.
Sanara MedTech's gross margin for the twelve months ending Jun 30, 2026 was 93.0%. For fiscal 2025 it was 92.7%, against 90.6% the year before. The highest annual figure on record is 92.7% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 92.7% | +2.1 |
| FY2024 | Dec 31, 2024 | 90.6% | +2.7 |
| FY2023 | Dec 31, 2023 | 87.9% | +1.8 |
| FY2022 | Dec 31, 2022 | 86.1% | −4.3 |
| FY2021 | Dec 31, 2021 | 90.4% | +0.8 |
| FY2020 | Dec 31, 2020 | 89.6% | −0.1 |
| FY2019 | Dec 31, 2019 | 89.7% | −1.6 |
| FY2018 | Dec 31, 2018 | 91.3% | +4.1 |
| FY2017 | Dec 31, 2017 | 87.2% | +4.3 |
| FY2016 | Dec 31, 2016 | 82.9% | +9.3 |
| FY2015 | Dec 31, 2015 | 73.5% | +4.1 |
| FY2014 | Dec 31, 2014 | 69.5% | +15.4 |
| FY2013 | Dec 31, 2013 | 54.1% | +22.1 |
| FY2012 | Dec 31, 2012 | 32.0% | −31.9 |
| FY2011 | Dec 31, 2011 | 63.8% | +22.9 |
| FY2010 | Dec 31, 2010 | 40.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 93.0% | +0.5 |
| Q1 FY2026 | Mar 31, 2026 | 93.1% | +0.9 |
| Q4 FY2025 | Dec 31, 2025 | 93.2% | +1.7 |
| Q3 FY2025 | Sep 30, 2025 | 92.9% | +2.1 |
| Q2 FY2025 | Jun 30, 2025 | 92.5% | +2.5 |
| Q1 FY2025 | Mar 31, 2025 | 92.2% | +2.4 |
| Q4 FY2024 | Dec 31, 2024 | 91.4% | +1.6 |
| Q3 FY2024 | Sep 30, 2024 | 90.8% | +1.7 |
| Q2 FY2024 | Jun 30, 2024 | 90.0% | +3.9 |
| Q1 FY2024 | Mar 31, 2024 | 89.8% | +3.5 |
| Q4 FY2023 | Dec 31, 2023 | 89.9% | +5.4 |
| Q3 FY2023 | Sep 30, 2023 | 89.1% | +6.2 |
| Q2 FY2023 | Jun 30, 2023 | 86.1% | −4.0 |
| Q1 FY2023 | Mar 31, 2023 | 86.3% | −3.4 |
| Q4 FY2022 | Dec 31, 2022 | 84.5% | −4.3 |
| Q3 FY2022 | Sep 30, 2022 | 82.9% | −8.2 |
| Q2 FY2022 | Jun 30, 2022 | 90.1% | −1.4 |
| Q1 FY2022 | Mar 31, 2022 | 89.7% | −0.8 |
| Q4 FY2021 | Dec 31, 2021 | 88.9% | −0.9 |
| Q3 FY2021 | Sep 30, 2021 | 91.1% | +1.5 |
| Q2 FY2021 | Jun 30, 2021 | 91.5% | +3.2 |
| Q1 FY2021 | Mar 31, 2021 | 90.5% | +41.3 |
| Q4 FY2020 | Dec 31, 2020 | 89.8% | −1.3 |
| Q3 FY2020 | Sep 30, 2020 | 89.6% | −0.6 |
| Q2 FY2020 | Jun 30, 2020 | 88.2% | −0.7 |
| Q1 FY2020 | Mar 31, 2020 | 49.2% | −39.2 |
| Q4 FY2019 | Dec 31, 2019 | 91.1% | +38.6 |
| Q3 FY2019 | Sep 30, 2019 | 90.2% | −2.4 |
| Q2 FY2019 | Jun 30, 2019 | 88.9% | −4.1 |
| Q1 FY2019 | Mar 31, 2019 | 88.4% | −0.9 |
| Q4 FY2018 | Dec 31, 2018 | 52.4% | −33.6 |
| Q3 FY2018 | Sep 30, 2018 | 92.6% | +7.5 |
| Q2 FY2018 | Jun 30, 2018 | 93.0% | +4.3 |
| Q1 FY2018 | Mar 31, 2018 | 89.2% | +0.1 |
| Q4 FY2017 | Dec 31, 2017 | 86.0% | +5.0 |
| Q3 FY2017 | Sep 30, 2017 | 85.1% | +0.2 |
| Q2 FY2017 | Jun 30, 2017 | 88.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 89.2% | – |
| Q4 FY2016 | Dec 31, 2016 | 81.0% | – |
| Q3 FY2016 | Sep 30, 2016 | 85.0% | – |
See a number that looks wrong?